President Donald Trump signed an executive order on Monday that recommends altering the childhood vaccination schedule in the United States, sparking immediate criticism from leading medical organizations. The order proposes splitting the measles, mumps, and rubella (MMR) vaccine into three separate shots and categorizing certain vaccines based on risk factors or physician consultations. The American Medical Association (AMA) condemned the move, warning that it could endanger children's health and erode public confidence in vaccines. According to the order, all children should receive individual vaccines for measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), pneumococcal disease, human papillomavirus (HPV), and varicella (chickenpox). However, the order suggests that only high-risk children should receive vaccines for respiratory syncytial virus (RSV) monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, and dengue. These changes mark a departure from previous federal guidelines, which included broader recommendations for these vaccines. Dr. Willie Underwood III, president of the AMA, expressed concern that the order undermines the scientific basis for current vaccination practices. “Vaccines are among the most thoroughly studied, effective tools we have to protect children from serious vaccine-preventable diseases,” he stated. “Decisions about how and when vaccines are used should be driven by rigorous scientific evidence, patient safety, and independent medical and public health expertise.” Underwood emphasized that altering a proven schedule without credible evidence risks undermining public trust and jeopardizing children’s health. The order also includes a directive for the Department of Health and Human Services (HHS) to enhance vaccine safety monitoring, transparency, and research. However, the recommendations have drawn sharp rebukes from other medical groups. Dr. Andrew Racine, president of the American Academy of Pediatrics (AAP), described the order as “not only disheartening but dangerous.” Outgoing Senator Bill Cassidy (R-La.), a former medical doctor, criticized the guidelines as “so wrong,” arguing that they lack expertise and could lead to increased vaccine hesitancy. Trump defended the changes during the signing ceremony, claiming that the revised schedule would help reduce autism rates in children. Despite the absence of scientific evidence linking vaccines to autism, he asserted that historical trends suggest a correlation. “Decades ago, children received only a small fraction of the vaccines required today. In those times, people were much healthier, and of course, the high rates of autism now observed did not exist,” he said. His remarks were supported by HHS Secretary Robert F. Kennedy Jr., who has previously promoted anti-vaccine sentiments. Critics argue that the proposed changes could complicate vaccination processes and potentially harm public health. Dr. Underwood noted that the AAP’s recommendations are grounded in disease-specific risks and healthcare delivery considerations within the U.S. He stressed that extensive scientific evidence supports the safety and efficacy of vaccines, emphasizing that parents should consult with physicians for any concerns. The order has also raised questions about the reliability of public health messaging. According to a recent survey by the Kaiser Family Foundation (KFF), a significant portion of parents fall into a “malleable middle” category, where beliefs about vaccines are inconsistent and more susceptible to misinformation. This group represents a critical segment of the population that could be influenced by conflicting messages about vaccine safety and necessity. The administration’s approach contrasts with international models, such as Denmark’s vaccination schedule, which uses combination vaccines to reduce the number of injections. While the U.S. currently recommends vaccines for 11 diseases, the order aims to further narrow this list, focusing on risk-based recommendations. However, experts warn that such an approach relies heavily on accurate identification of risk factors, which requires robust screening and access to healthcare services, areas where the U.S. lags behind many other developed nations. As the debate continues, the implications of the executive order remain unclear. The changes could affect both public health outcomes and the broader landscape of vaccine policy in the United States. The long-term impact will depend on how effectively the administration communicates these changes and how the medical community responds to the challenges posed by the new guidelines.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter
United States
